Humanized antibodies that bind to CD19 and their uses

Details for Australian Patent Application No. 2010215239 (hide)

Owner GLENMARK PHARMACEUTICALS S.A.

Inventors Blein, Stanislas; Skegro, Darko; Debonneville, Christophe; Bertschinger, Martin

Agent Collison & Co

Pub. Number AU-A-2010215239

PCT Pub. Number WO2010/095031

Priority 61/154,524 23.02.09 US

Filing date 23 February 2010

Wipo publication date 26 August 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 September 2011 PCT application entered the National Phase

  PCT publication WO2010/095031 Priority application(s): WO2010/095031

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215243-Plasma crucible sealing

2010215234-Segmented track